[Significance of BCR-ABL fusion gene detection in CD34 (+) cells of chronic myelogenous leukemia patients].
作者信息
Ma Y X, Wang L, Mi R H, Wang X W, Lyu X D, Fan R H, Wei X D
机构信息
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450008, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2017 Feb 14;38(2):164-166. doi: 10.3760/cma.j.issn.0253-2727.2017.02.016.
Abstract
摘要
相似文献
1
[Significance of BCR-ABL fusion gene detection in CD34 (+) cells of chronic myelogenous leukemia patients].
Zhonghua Xue Ye Xue Za Zhi. 2017 Feb 14;38(2):164-166. doi: 10.3760/cma.j.issn.0253-2727.2017.02.016.
2
3
Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia.
Leukemia. 2001 Jan;15(1):62-8. doi: 10.1038/sj.leu.2402005.
4
The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients.
J Immunol. 2002 Jan 15;168(2):643-50. doi: 10.4049/jimmunol.168.2.643.
5
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment.
Blood. 2005 Mar 1;105(5):2093-8. doi: 10.1182/blood-2004-03-1114. Epub 2004 Sep 2.
6
7
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.
Blood. 2003 Jun 15;101(12):4701-7. doi: 10.1182/blood-2002-09-2780. Epub 2003 Feb 6.
8
BCR/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia.
Mol Cancer Ther. 2003 Feb;2(2):173-82.
9
A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector.
Blood. 2001 Apr 15;97(8):2406-12. doi: 10.1182/blood.v97.8.2406.
10
本文引用的文献
1
Cell sorting enables interphase fluorescence in situ hybridization detection of low BCR-ABL1 producing stem cells in chronic myeloid leukaemia patients beyond deep molecular remission.
Br J Haematol. 2014 Jan;164(1):53-60. doi: 10.1111/bjh.12589.
2
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study.
Blood. 2013 Jul 25;122(4):515-22. doi: 10.1182/blood-2013-02-483750. Epub 2013 May 23.
3
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response.
Leuk Res. 2012 Jun;36(6):689-93. doi: 10.1016/j.leukres.2012.02.011. Epub 2012 Mar 5.
4
Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia.
Haematologica. 2012 Jun;97(6):903-6. doi: 10.3324/haematol.2011.056853. Epub 2011 Dec 16.
5
Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease.
Blood. 2011 Sep 29;118(13):3657-60. doi: 10.1182/blood-2011-02-335497. Epub 2011 Jul 25.
6
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.
Lancet Oncol. 2010 Nov;11(11):1029-35. doi: 10.1016/S1470-2045(10)70233-3. Epub 2010 Oct 19.
7
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.
J Natl Compr Canc Netw. 2009 Oct;7(9):984-1023. doi: 10.6004/jnccn.2009.0065.
8
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.
Blood. 2007 Jan 1;109(1):58-60. doi: 10.1182/blood-2006-03-011239. Epub 2006 Sep 14.
9
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.
Leukemia. 2003 Dec;17(12):2474-86. doi: 10.1038/sj.leu.2403136.
Zotero 插件